Four leading organizations in lifestyle medicine, obesity medicine, and nutrition-the American College of Lifestyle Medicine ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

When Michael Donnelly-Boylen was diagnosed with type 2 diabetes, he knew he had to "fight" to lose weight. Starting Mounjaro ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...